BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26643453)

  • 21. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
    Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification.
    Escalante P; Peikert T; Van Keulen VP; Erskine CL; Bornhorst CL; Andrist BR; McCoy K; Pease LR; Abraham RS; Knutson KL; Kita H; Schrum AG; Limper AH
    Am J Respir Crit Care Med; 2015 Sep; 192(5):605-17. PubMed ID: 26030344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
    Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
    Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 100 year update on diagnosis of tuberculosis infection.
    Lalvani A; Pareek M
    Br Med Bull; 2010; 93():69-84. PubMed ID: 19926636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-γ release assay for the diagnosis of latent Mycobacterium tuberculosis infection in children younger than 5 years: a meta-analysis.
    Ge L; Ma JC; Han M; Li JL; Tian JH
    Clin Pediatr (Phila); 2014 Nov; 53(13):1255-63. PubMed ID: 24970465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte-Related Immunological Indicators for Stratifying
    Luo Y; Xue Y; Tang G; Cai Y; Yuan X; Lin Q; Song H; Liu W; Mao L; Zhou Y; Chen Z; Zhu Y; Liu W; Wu S; Wang F; Sun Z
    Front Immunol; 2021; 12():658843. PubMed ID: 34276653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
    Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
    Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.
    Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT.
    Hoffmann H; Avsar K; Göres R; Mavi SC; Hofmann-Thiel S
    Clin Microbiol Infect; 2016 Aug; 22(8):701-3. PubMed ID: 27184875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection.
    Lichtner M; Mascia C; Sauzullo I; Mengoni F; Vita S; Marocco R; Belvisi V; Russo G; Vullo V; Mastroianni CM
    J Immunol Res; 2015; 2015():217287. PubMed ID: 26339657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
    Wyrożemski Ł; Sollid LM; Qiao SW
    Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma.
    González-Hernández Y; Pedraza-Sánchez S; Blandón-Vijil V; del Río-Navarro BE; Vaughan G; Moreno-Lafont M; Escobar-Gutiérrez A
    Scand J Immunol; 2007 Apr; 65(4):368-75. PubMed ID: 17386028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current Issues Arising from Tuberculosis Screening with Interferon-Gamma-Release Assays (IGRAs)].
    Diel R; Nienhaus A
    Pneumologie; 2015 May; 69(5):271-5. PubMed ID: 25970120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
    Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
    Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.